알레르기 주사제 시장 - 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2031년) - 제품별, 면역 요법별, 적응증별, 알레르겐별, 유통 채널별, 지역별

Allergy Shots Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

US $ 4,995 ￦ 7,216,000

Unprintable PDF & Excel (Single User License)

PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 텍스트의 Copy&Paste도 불가능합니다.

US $ 8,495 ￦ 12,273,000

Unprintable PDF & Excel (Multi User License upto 5 users)

PDF 및 Excel 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 텍스트는 Copy & Paste 가능하지만, 인쇄는 불가능합니다.

US $ 10,600 ￦ 15,314,000

Printable PDF & Excel (Enterprise License above 5 users)

PDF 및 Excel 보고서를 동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용자수는 5명 이상이며 제한은 없습니다. Copy & Paste 및 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 알레르기 주사제 시장 규모는 2024년 약 26억 달러에서 2031년 말에는 62억 달러로 크게 성장할 것으로 예상됩니다.

세계 알레르기 주사제 시장은 강력한 성장세를 보이고 있으며, 그 주요 요인은 세계적으로 다양한 알레르기의 발생률이 증가하고 있기 때문입니다. 알레르기성 비염(AR), 비알레르기성 비염(NAR), 비특이적 비염의 유병률 중앙값은 각각 29.4%, 18.1%, 12.0%로 지역에 따라 차이가 있습니다. 이러한 비염의 빈도 증가는 도시화 된 문화의 도입, 공해, 식습관 장애, 알코올 사용 등과 함께 음식 알레르기 및 피부 알레르기를 포함한 알레르기 반응의 급격한 증가로 이어졌습니다. 라이프스타일의 진화와 함께 알레르기 주사 치료에 대한 수요가 증가하면서 시장 확대의 원동력이 되고 있습니다.

또한, 특수 치료제와 재조합 면역 요법의 발전으로 시장은 끊임없이 진화하고 있습니다. 각 제조업체는 제품 포트폴리오를 확장하고 고객 기반을 확대하며 지리적 범위를 넓히기 위해 합병, 인수, 제휴 및 파트너십을 적극적으로 추진하고 있습니다.

알레르기 주사제 시장은 유망한 성장세에도 불구하고 여러 가지 문제에 직면해 있습니다. 알레르기 주사제의 치료 기간이 길고, 알레르기의 성격과 단계에 따라 최대 3-5년 정도 소요됩니다. 환자들은 나이, 건강 상태, 위치, 경제적 제약으로 인해 치료를 중단하는 경우가 많아 시장 확대에 걸림돌이 되고 있습니다.

또한, 알레르기 주사제 및 정제의 부작용도 시장 축소에 한몫을 하고 있습니다. 환자의 10% 이상이 부작용을 경험하고 있으며, 대부분 구강 소양증이나 인후통과 같은 경증에서 중증의 국소 반응입니다.

본 보고서는 세계 알레르기 주사제 시장에 대해 조사했으며, 시장 개요와 함께 제품별, 면역요법별, 적응증별, 알레르겐별, 유통채널별, 지역별 동향, 시장 진출기업의 경쟁 동향 등을 정리하여 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의와 세분화
• 시장 역학
• 밸류체인 분석
• Porter의 Five Forces 분석
• COVID-19의 영향 분석
• 우크라이나와 러시아 분쟁의 영향
• 경제 개요
• PESTLE 분석

제3장 생산고와 무역통계, 2018년-2023년

제4장 가격 분석, 2018년-2023년

제5장 세계의 알레르기용 주사제시장 전망, 2018년-2031년

• 세계의 알레르기용 주사제시장 전망, 제품별, 금액(100만 달러), 수량(개)별, 2018년-2031년
• 세계의 알레르기용 주사제시장 전망, 면역치료별, 금액(100만 달러), 수량(개), 2018년-2031년
• 세계의 알레르기용 주사제시장 전망, 적응증별, 금액(100만 달러), 수량(개), 2018년-2031년
• 세계의 알레르기용 주사제시장 전망, 알레르겐별, 금액(100만 달러), 수량(개), 2018년-2031년
• 세계의 알레르기용 주사제시장 전망, 유통 채널별, 금액(100만 달러), 수량(개), 2018년-2031년
• 세계의 알레르기용 주사제시장 전망, 지역별, 금액(100만 달러), 수량(개), 2018년-2031년

제6장 북미 알레르기용 주사제시장 전망, 2018년-2031년

제7장 유럽 알레르기용 주사제시장 전망, 2018년-2031년

제8장 아시아태평양 알레르기용 주사제시장 전망, 2018년-2031년

제9장 라틴아메리카 알레르기용 주사제시장 전망, 2018년-2031년

제10장 중동 및 아프리카 알레르기용 주사제시장 전망, 2018년-2031년

제11장 경쟁 구도

• 유형별 대 면역치료별 히트맵
• 제조업체와 면역치료별 히트맵
• 기업의 시장 점유율 분석, 2023년
• 경쟁력 대시보드
• 기업 개요
  • Stallergenes Greer
  • Allergy Therapeutics
  • Aimmune Therapeutics
  • Anergis
  • Arrayit Corporation
  • Biomay AG
  • HAL Allergy Group
  • DBV Technologies

제12장 부록

LSH

영문 목차

영문목차

The global Allergy Shots Market is poised for substantial growth, propelling the market valuation from approximately US$ 2.6 billion in 2024 to an estimated US$ 6.2 billion by the end of 2031.

Driving Factors

The global Allergy Shots Market is experiencing robust growth, primarily attributed to the escalating incidence of various allergy types worldwide. Allergic rhinitis (AR), non-allergic rhinitis (NAR), and nonspecific rhinitis have shown median prevalence rates of 29.4%, 18.1%, and 12.0%, respectively, with variations by region. This increasing frequency of rhinitis, combined with the adoption of urbanized cultures, pollution, poor dietary habits, and alcohol use, has led to a surge in allergic reactions, including food and skin allergies. As lifestyles evolve, the demand for allergy shots treatments is rising, driving market expansion.

Moreover, the market continually evolves with advancements in specialized therapeutics and recombinant immunotherapies. Manufacturers are embracing mergers, acquisitions, collaborations, and partnerships to broaden their product portfolios, extend their client base, and expand their geographic reach.

Challenges and Barriers

Despite its promising growth, the Allergy Shots Market faces challenges. The treatment course for Allergy Shots is lengthy, lasting up to 3 to 5 years depending on the allergy's nature and stage. Patients often discontinue treatment midway due to age, health, location, or financial constraints, hindering market expansion.

Additionally, adverse side effects associated with allergy injections and tablets have contributed to a market decline. More than 10% of patients reported experiencing adverse reactions, with the majority being mild to severe local reactions such as oral pruritus or throat discomfort.

Country-wise Insights

• United States: The U.S. market is booming due to increased investments by regional key players in advanced product development, offering user-friendly solutions with rapid results. For example, Moonlight Therapeutics received $1.9 million in funding for preclinical investigations and product development for peanut allergy treatment.

• Germany: Germany is emerging as a lucrative market with a focus on increasing product launches. In September 2019, the introduction of ITULAZAX, an efficient sublingual Allergy Shots tablet for tree pollen allergy, marked a significant development.

• Japan: Japan is becoming a prominent market driven by the increasing prevalence of allergic rhinitis, affecting 10-30% of individuals globally. The high sensitivity of pollen from trees and grass in the region necessitates effective allergy treatments.

Competitive Landscape

The Allergy Shots Market is marked by a consolidated landscape with a small number of significant market players. Leading companies such as Aimmune Therapeutics, Hollister Allergy, Leti Pharma, and Merck KGaA are driving market growth through strategies like mergers and acquisitions, expansion, new product development, and alliances.

Key Companies Covered

• Stallergenes Greer
• Allergy Therapeutics
• Aimmune Therapeutics
• Anergis
• Arrayit Corporation
• Biomay AG
• HAL Allergy Group
• DBV Technologies
• ALK Abello

Key Segments Covered in Allergy Shots Industry Research

Product:

• SLIT Tablets
  • Odactra
  • Grastek
  • Ragwitek
  • Oralair
  • Actair
  • Others

• Oral
  • Palforzia

• Others
  • Injections
  • Others

Immunotherapy:

• Sublingual Immunotherapy (SLIT)
• Subcutaneous Immunotherapy (SCIT)
  • Specific Immunotherapy

• Others

Indication:

• Allergic Rhinitis
• Allergic Asthma
• Food Allergy
• Atopic Dermatitis
• Others

Allergen:

• Pollens
  • Grass Pollens
  • Weed Pollens
  • Tree Pollens
    • House Dust Mites (HDM)
    • Mold
    • Animal Dander
    • Bee Venom
    • Cockroaches/Insects
    • Others

Distribution Channel:

• Institutional Sales
  • Government Hospitals
  • Semi-Government Hospitals
  • Private Hospitals

• Retail Sales
  • Retail Pharmacy
  • Drug Stores
  • Online Pharmacy

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Allergy Shots Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value and Volume, 2023
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Production Output and Trade Statistics, 2018 - 2023

• 3.1. Global Allergy Shots Market Production Output, by Region, Value (US$ Bn) and Volume ('000 Units), 2018 - 2023
  • 3.1.1. North America
  • 3.1.2. Europe
  • 3.1.3. Asia Pacific
  • 3.1.4. Latin America
  • 3.1.5. Middle East and Africa

4. Price Analysis, 2018 - 2023

• 4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2018 - 2023
• 4.2. Prominent Factor Affecting Allergy Shots Prices
• 4.3. Global Average Price Analysis, by Region, US$ Per Unit

5. Global Allergy Shots Market Outlook, 2018 - 2031

• 5.1. Global Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 5.1.1. Key Highlights
    • 5.1.1.1. SLIT Tablets
      • 5.1.1.1.1. Odactra
      • 5.1.1.1.2. Grastek
      • 5.1.1.1.3. Ragwitek
      • 5.1.1.1.4. Oralair
      • 5.1.1.1.5. Actair
      • 5.1.1.1.6. Others
    • 5.1.1.2. Oral
      • 5.1.1.2.1. Palforzia
      • 5.1.1.2.2. Others
    • 5.1.1.3. Injections
    • 5.1.1.4. Others
• 5.2. Global Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 5.2.1. Key Highlights
    • 5.2.1.1. Sublingual Immunotherapy (SLIT)
    • 5.2.1.2. Subcutaneous Immunotherapy (SCIT)
      • 5.2.1.2.1. Specific Immunotherapy
    • 5.2.1.3. Others
• 5.3. Global Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 5.3.1. Key Highlights
    • 5.3.1.1. Allergic Rhinitis
    • 5.3.1.2. Allergic Asthma
    • 5.3.1.3. Food Allergy
    • 5.3.1.4. Atopic Dermatitis
    • 5.3.1.5. Others
• 5.4. Global Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 5.4.1. Key Highlights
    • 5.4.1.1. Pollens
      • 5.4.1.1.1. Grass Pollens
      • 5.4.1.1.2. Weed Pollens
      • 5.4.1.1.3. Tree Pollens
    • 5.4.1.2. House Dust Mites (HDM)
    • 5.4.1.3. Mold
    • 5.4.1.4. Animal Dander
    • 5.4.1.5. Bee Venom
    • 5.4.1.6. Cockroaches/Insects
    • 5.4.1.7. Others
• 5.5. Others Global Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 5.5.1. Key Highlights
    • 5.5.1.1. Institutional Sales
      • 5.5.1.1.1. Government Hospitals
      • 5.5.1.1.2. Semi-Government Hospitals
      • 5.5.1.1.3. Private Hospitals
    • 5.5.1.2. Retail Sales
      • 5.5.1.2.1. Retail Pharmacy
      • 5.5.1.2.2. Drug Stores
      • 5.5.1.2.3. Online Pharmacy
• 5.6. Global Allergy Shots Market Outlook, by Region, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 5.6.1. Key Highlights
    • 5.6.1.1. North America
    • 5.6.1.2. Europe
    • 5.6.1.3. Asia Pacific
    • 5.6.1.4. Latin America
    • 5.6.1.5. Middle East & Africa

6. North America Allergy Shots Market Outlook, 2018 - 2031

• 6.1. North America Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 6.1.1. Key Highlights
    • 6.1.1.1. SLIT Tablets
      • 6.1.1.1.1. Odactra
      • 6.1.1.1.2. Grastek
      • 6.1.1.1.3. Ragwitek
      • 6.1.1.1.4. Oralair
      • 6.1.1.1.5. Actair
      • 6.1.1.1.6. Others
    • 6.1.1.2. Oral
      • 6.1.1.2.1. Palforzia
      • 6.1.1.2.2. Others
    • 6.1.1.3. Injections
    • 6.1.1.4. Others
• 6.2. North America Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 6.2.1. Key Highlights
    • 6.2.1.1. Sublingual Immunotherapy (SLIT)
    • 6.2.1.2. Subcutaneous Immunotherapy (SCIT)
      • 6.2.1.2.1. Specific Immunotherapy
    • 6.2.1.3. Others
• 6.3. North America Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 6.3.1. Key Highlights
    • 6.3.1.1. Allergic Rhinitis
    • 6.3.1.2. Allergic Asthma
    • 6.3.1.3. Food Allergy
    • 6.3.1.4. Atopic Dermatitis
    • 6.3.1.5. Others
• 6.4. North America Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 6.4.1. Key Highlights
    • 6.4.1.1. Pollens
      • 6.4.1.1.1. Grass Pollens
      • 6.4.1.1.2. Weed Pollens
      • 6.4.1.1.3. Tree Pollens
    • 6.4.1.2. House Dust Mites (HDM)
    • 6.4.1.3. Mold
    • 6.4.1.4. Animal Dander
    • 6.4.1.5. Bee Venom
    • 6.4.1.6. Cockroaches/Insects
    • 6.4.1.7. Others
• 6.5. North America Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 6.5.1. Key Highlights
    • 6.5.1.1. Institutional Sales
      • 6.5.1.1.1. Government Hospitals
      • 6.5.1.1.2. Semi-Government Hospitals
      • 6.5.1.1.3. Private Hospitals
    • 6.5.1.2. Retail Sales
      • 6.5.1.2.1. Retail Pharmacy
      • 6.5.1.2.2. Drug Stores
      • 6.5.1.2.3. Online Pharmacy
  • 6.5.2. BPS Analysis/Market Attractiveness Analysis
• 6.6. North America Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 6.6.1. Key Highlights
    • 6.6.1.1. U.S. Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.6.1.2. U.S. Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.6.1.3. U.S. Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.6.1.4. U.S. Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.6.1.5. U.S. Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.6.1.6. Canada Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.6.1.7. Canada Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.6.1.8. Canada Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.6.1.9. Canada Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 6.6.1.10. Canada Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 6.6.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Allergy Shots Market Outlook, 2018 - 2031

• 7.1. Europe Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 7.1.1. Key Highlights
    • 7.1.1.1. SLIT Tablets
      • 7.1.1.1.1. Odactra
      • 7.1.1.1.2. Grastek
      • 7.1.1.1.3. Ragwitek
      • 7.1.1.1.4. Oralair
      • 7.1.1.1.5. Actair
      • 7.1.1.1.6. Others
    • 7.1.1.2. Oral
      • 7.1.1.2.1. Palforzia
      • 7.1.1.2.2. Others
    • 7.1.1.3. Injections
    • 7.1.1.4. Others
• 7.2. Europe Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 7.2.1. Key Highlights
    • 7.2.1.1. Sublingual Immunotherapy (SLIT)
    • 7.2.1.2. Subcutaneous Immunotherapy (SCIT)
      • 7.2.1.2.1. Specific Immunotherapy
    • 7.2.1.3. Others
• 7.3. Europe Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 7.3.1. Key Highlights
    • 7.3.1.1. Allergic Rhinitis
    • 7.3.1.2. Allergic Asthma
    • 7.3.1.3. Food Allergy
    • 7.3.1.4. Atopic Dermatitis
    • 7.3.1.5. Others
• 7.4. Europe Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 7.4.1. Key Highlights
    • 7.4.1.1. Pollens
      • 7.4.1.1.1. Grass Pollens
      • 7.4.1.1.2. Weed Pollens
      • 7.4.1.1.3. Tree Pollens
    • 7.4.1.2. House Dust Mites (HDM)
    • 7.4.1.3. Mold
    • 7.4.1.4. Animal Dander
    • 7.4.1.5. Bee Venom
    • 7.4.1.6. Cockroaches/Insects
    • 7.4.1.7. Others
• 7.5. Europe Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 7.5.1. Key Highlights
    • 7.5.1.1. Institutional Sales
      • 7.5.1.1.1. Government Hospitals
      • 7.5.1.1.2. Semi-Government Hospitals
      • 7.5.1.1.3. Private Hospitals
    • 7.5.1.2. Retail Sales
      • 7.5.1.2.1. Retail Pharmacy
      • 7.5.1.2.2. Drug Stores
      • 7.5.1.2.3. Online Pharmacy
  • 7.5.2. BPS Analysis/Market Attractiveness Analysis
• 7.6. Europe Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 7.6.1. Key Highlights
    • 7.6.1.1. Germany Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.2. Germany Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.3. Germany Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.4. Germany Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.5. Germany Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.6. U.K. Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.7. U.K. Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.8. U.K. Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.9. U.K. Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.10. U.K. Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.11. France Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.12. France Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.13. France Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.14. France Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.15. France Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.16. Italy Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.17. Italy Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.18. Italy Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.19. Italy Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.20. Italy Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.21. Turkey Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.22. Turkey Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.23. Turkey Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.24. Turkey Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.25. Turkey Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.26. Russia Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.27. Russia Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.28. Russia Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.29. Russia Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.30. Russia Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.31. Rest of Europe Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.32. Rest of Europe Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.33. Rest of Europe Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.34. Rest of Europe Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 7.6.1.35. Rest of Europe Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 7.6.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Allergy Shots Market Outlook, 2018 - 2031

• 8.1. Asia Pacific Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 8.1.1. Key Highlights
    • 8.1.1.1. SLIT Tablets
      • 8.1.1.1.1. Odactra
      • 8.1.1.1.2. Grastek
      • 8.1.1.1.3. Ragwitek
      • 8.1.1.1.4. Oralair
      • 8.1.1.1.5. Actair
      • 8.1.1.1.6. Others
    • 8.1.1.2. Oral
      • 8.1.1.2.1. Palforzia
      • 8.1.1.2.2. Others
    • 8.1.1.3. Injections
    • 8.1.1.4. Others
• 8.2. Asia Pacific Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 8.2.1. Key Highlights
    • 8.2.1.1. Sublingual Immunotherapy (SLIT)
    • 8.2.1.2. Subcutaneous Immunotherapy (SCIT)
      • 8.2.1.2.1. Specific Immunotherapy
    • 8.2.1.3. Others
• 8.3. Asia Pacific Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 8.3.1. Key Highlights
    • 8.3.1.1. Allergic Rhinitis
    • 8.3.1.2. Allergic Asthma
    • 8.3.1.3. Food Allergy
    • 8.3.1.4. Atopic Dermatitis
    • 8.3.1.5. Others
• 8.4. Asia Pacific Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 8.4.1. Key Highlights
    • 8.4.1.1. Pollens
      • 8.4.1.1.1. Grass Pollens
      • 8.4.1.1.2. Weed Pollens
      • 8.4.1.1.3. Tree Pollens
    • 8.4.1.2. House Dust Mites (HDM)
    • 8.4.1.3. Mold
    • 8.4.1.4. Animal Dander
    • 8.4.1.5. Bee Venom
    • 8.4.1.6. Cockroaches/Insects
    • 8.4.1.7. Others
• 8.5. Asia Pacific Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 8.5.1. Key Highlights
    • 8.5.1.1. Institutional Sales
      • 8.5.1.1.1. Government Hospitals
      • 8.5.1.1.2. Semi-Government Hospitals
      • 8.5.1.1.3. Private Hospitals
    • 8.5.1.2. Retail Sales
      • 8.5.1.2.1. Retail Pharmacy
      • 8.5.1.2.2. Drug Stores
      • 8.5.1.2.3. Online Pharmacy
  • 8.5.2. BPS Analysis/Market Attractiveness Analysis
• 8.6. Asia Pacific Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 8.6.1. Key Highlights
    • 8.6.1.1. China Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.2. China Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.3. China Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.4. China Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.5. China Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.6. Japan Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.7. Japan Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.8. Japan Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.9. Japan Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.10. Japan Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.11. South Korea Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.12. South Korea Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.13. South Korea Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.14. South Korea Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.15. South Korea Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.16. India Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.17. India Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.18. India Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.19. India Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.20. India Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.21. Southeast Asia Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.22. Southeast Asia Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.23. Southeast Asia Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.24. Southeast Asia Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.25. Southeast Asia Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.26. Rest of Asia Pacific Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.27. Rest of Asia Pacific Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.28. Rest of Asia Pacific Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.29. Rest of Asia Pacific Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 8.6.1.30. Rest of Asia Pacific Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 8.6.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Allergy Shots Market Outlook, 2018 - 2031

• 9.1. Latin America Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 9.1.1. Key Highlights
    • 9.1.1.1. SLIT Tablets
      • 9.1.1.1.1. Odactra
      • 9.1.1.1.2. Grastek
      • 9.1.1.1.3. Ragwitek
      • 9.1.1.1.4. Oralair
      • 9.1.1.1.5. Actair
      • 9.1.1.1.6. Others
    • 9.1.1.2. Oral
      • 9.1.1.2.1. Palforzia
      • 9.1.1.2.2. Others
    • 9.1.1.3. Injections
    • 9.1.1.4. Others
• 9.2. Latin America Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 9.2.1.1. Sublingual Immunotherapy (SLIT)
  • 9.2.1.2. Subcutaneous Immunotherapy (SCIT)
    • 9.2.1.2.1. Specific Immunotherapy
  • 9.2.1.3. Others
• 9.3. Latin America Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 9.3.1. Key Highlights
    • 9.3.1.1. Allergic Rhinitis
    • 9.3.1.2. Allergic Asthma
    • 9.3.1.3. Food Allergy
    • 9.3.1.4. Atopic Dermatitis
    • 9.3.1.5. Others
• 9.4. Latin America Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 9.4.1. Key Highlights
    • 9.4.1.1. Pollens
      • 9.4.1.1.1. Grass Pollens
      • 9.4.1.1.2. Weed Pollens
      • 9.4.1.1.3. Tree Pollens
    • 9.4.1.2. House Dust Mites (HDM)
    • 9.4.1.3. Mold
    • 9.4.1.4. Animal Dander
    • 9.4.1.5. Bee Venom
    • 9.4.1.6. Cockroaches/Insects
    • 9.4.1.7. Others
• 9.5. Latin America Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 9.5.1. Key Highlights
    • 9.5.1.1. Institutional Sales
      • 9.5.1.1.1. Government Hospitals
      • 9.5.1.1.2. Semi-Government Hospitals
      • 9.5.1.1.3. Private Hospitals
    • 9.5.1.2. Retail Sales
      • 9.5.1.2.1. Retail Pharmacy
      • 9.5.1.2.2. Drug Stores
      • 9.5.1.2.3. Online Pharmacy
  • 9.5.2. BPS Analysis/Market Attractiveness Analysis
• 9.6. Latin America Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 9.6.1. Key Highlights
    • 9.6.1.1. Brazil Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1.2. Brazil Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1.3. Brazil Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1.4. Brazil Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1.5. Brazil Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1.6. Mexico Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1.7. Mexico Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1.8. Mexico Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1.9. Mexico Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1.10. Mexico Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1.11. Argentina Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1.12. Argentina Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1.13. Argentina Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1.14. Argentina Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1.15. Argentina Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1.16. Rest of Latin America Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1.17. Rest of Latin America Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1.18. Rest of Latin America Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1.19. Rest of Latin America Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 9.6.1.20. Rest of Latin America Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 9.6.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Allergy Shots Market Outlook, 2018 - 2031

• 10.1. Middle East & Africa Allergy Shots Market Outlook, by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 10.1.1. Key Highlights
    • 10.1.1.1. SLIT Tablets
      • 10.1.1.1.1. Odactra
      • 10.1.1.1.2. Grastek
      • 10.1.1.1.3. Ragwitek
      • 10.1.1.1.4. Oralair
      • 10.1.1.1.5. Actair
      • 10.1.1.1.6. Others
    • 10.1.1.2. Oral
      • 10.1.1.2.1. Palforzia
      • 10.1.1.2.2. Others
    • 10.1.1.3. Injections
    • 10.1.1.4. Others
• 10.2. Middle East & Africa Allergy Shots Market Outlook, by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 10.2.1. Key Highlights
    • 10.2.1.1. Sublingual Immunotherapy (SLIT)
    • 10.2.1.2. Subcutaneous Immunotherapy (SCIT)
      • 10.2.1.2.1. Specific Immunotherapy
    • 10.2.1.3. Others
• 10.3. Middle East & Africa Allergy Shots Market Outlook, by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 10.3.1. Key Highlights
    • 10.3.1.1. Allergic Rhinitis
    • 10.3.1.2. Allergic Asthma
    • 10.3.1.3. Food Allergy
    • 10.3.1.4. Atopic Dermatitis
    • 10.3.1.5. Others
• 10.4. Middle East & Africa Allergy Shots Market Outlook, by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 10.4.1. Key Highlights
    • 10.4.1.1. Cell Wall Synthesis Inhibitors
    • 10.4.1.2. Protein Synthesis Inhibitors
    • 10.4.1.3. DNA Synthesis Inhibitors
    • 10.4.1.4. RNA Synthesis Inhibitors
    • 10.4.1.5. Others
• 10.5. Middle East & Africa Allergy Shots Market Outlook, by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 10.5.1. Key Highlights
    • 10.5.1.1. Institutional Sales
      • 10.5.1.1.1. Government Hospitals
      • 10.5.1.1.2. Semi-Government Hospitals
      • 10.5.1.1.3. Private Hospitals
    • 10.5.1.2. Retail Sales
      • 10.5.1.2.1. Retail Pharmacy
      • 10.5.1.2.2. Drug Stores
      • 10.5.1.2.3. Online Pharmacy
  • 10.5.2. BPS Analysis/Market Attractiveness Analysis
• 10.6. Middle East & Africa Allergy Shots Market Outlook, by Country, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 10.6.1. Key Highlights
    • 10.6.1.1. GCC Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.2. GCC Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.3. GCC Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.4. GCC Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.5. GCC Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.6. South Africa Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.7. South Africa Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.8. South Africa Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.9. South Africa Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.10. South Africa Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.11. Egypt Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.12. Egypt Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.13. Egypt Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.14. Egypt Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.15. Egypt Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.16. Nigeria Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.17. Nigeria Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.18. Nigeria Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.19. Nigeria Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.20. Nigeria Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.21. Rest of Middle East & Africa Allergy Shots Market by Product, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.22. Rest of Middle East & Africa Allergy Shots Market by Immunotherapy, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.23. Rest of Middle East & Africa Allergy Shots Market by Indication, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.24. Rest of Middle East & Africa Allergy Shots Market by Allergen, Value (US$ Mn) and Volume (Units), 2018 - 2031
    • 10.6.1.25. Rest of Middle East & Africa Allergy Shots Market by Distribution channel, Value (US$ Mn) and Volume (Units), 2018 - 2031
  • 10.6.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

• 11.1. By Species vs by Immunotherapy Heat map
• 11.2. Manufacturer vs by Immunotherapy Heat map
• 11.3. Company Market Share Analysis, 2023
• 11.4. Competitive Dashboard
• 11.5. Company Profiles
  • 11.5.1. Stallergenes Greer
    • 11.5.1.1. Company Overview
    • 11.5.1.2. Product Portfolio
    • 11.5.1.3. Financial Overview
    • 11.5.1.4. Business Strategies and Development
  • 11.5.2. Allergy Therapeutics
    • 11.5.2.1. Company Overview
    • 11.5.2.2. Product Portfolio
    • 11.5.2.3. Financial Overview
    • 11.5.2.4. Business Strategies and Development
  • 11.5.3. Aimmune Therapeutics
    • 11.5.3.1. Company Overview
    • 11.5.3.2. Product Portfolio
    • 11.5.3.3. Financial Overview
    • 11.5.3.4. Business Strategies and Development
  • 11.5.4. Anergis
    • 11.5.4.1. Company Overview
    • 11.5.4.2. Product Portfolio
    • 11.5.4.3. Financial Overview
    • 11.5.4.4. Business Strategies and Development
  • 11.5.5. Arrayit Corporation
    • 11.5.5.1. Company Overview
    • 11.5.5.2. Product Portfolio
    • 11.5.5.3. Financial Overview
    • 11.5.5.4. Business Strategies and Development
  • 11.5.6. Biomay AG
    • 11.5.6.1. Company Overview
    • 11.5.6.2. Product Portfolio
    • 11.5.6.3. Financial Overview
    • 11.5.6.4. Business Strategies and Development
  • 11.5.7. HAL Allergy Group
    • 11.5.7.1. Company Overview
    • 11.5.7.2. Product Portfolio
    • 11.5.7.3. Financial Overview
    • 11.5.7.4. Business Strategies and Development
  • 11.5.8. DBV Technologies
    • 11.5.8.1. Company Overview
    • 11.5.8.2. Product Portfolio
    • 11.5.8.3. Financial Overview
    • 11.5.8.4. Business Strategies and Development

12. Appendix

• 12.1. Research Methodology
• 12.2. Report Assumptions
• 12.3. Acronyms and Abbreviations

관련자료